{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:10:56Z","timestamp":1792174256224,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T00:00:00Z","timestamp":1312243200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-244x-11-124","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T02:26:08Z","timestamp":1312338368000},"source":"Crossref","is-referenced-by-count":150,"title":["Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients"],"prefix":"10.1186","volume":"11","author":[{"given":"Monia","family":"Raffa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Atig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhamid","family":"Kerkeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Mechri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,2]]},"reference":[{"key":"861_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11427-010-0013-8","volume":"53","author":"M Zhang","year":"2010","unstructured":"Zhang M, Zhao Z, He L, Wan C: Ameta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci. 2010, 53: 112-124. 10.1007\/s11427-010-0013-8.","journal-title":"Sci China Life Sci"},{"key":"861_CR2","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","volume":"35","author":"KY Bitanihirwe Byron","year":"2011","unstructured":"Bitanihirwe Byron KY, Woo Tsun-Ung W: Oxidative stress in schizophrenia: An integrated approach. Neuroscience and Biobehavioral. 2011, 35: 878-893. 10.1016\/j.neubiorev.2010.10.008.","journal-title":"Neuroscience and Biobehavioral"},{"key":"861_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0920-9964(95)00048-8","volume":"19","author":"S Mukherjee","year":"1996","unstructured":"Mukherjee S, Mahadik SP, Scheffer R, Correnti EE, Kelkar H: Impaired antioxidant defense at the onset of psychosis. Schizophr Res. 1996, 19: 19-26. 10.1016\/0920-9964(95)00048-8.","journal-title":"Schizophr Res"},{"key":"861_CR4","first-page":"45","volume":"55","author":"JR Drevet","year":"2006","unstructured":"Drevet JR: The antioxidant glutathione peroxidase family and spermatozoa: A complex story. MCE. Essent Fatty Acids. 2006, 55: 45-54.","journal-title":"Essent Fatty Acids"},{"key":"861_CR5","volume-title":"Best Pract Res Clin Obstet Gynaecol","author":"J Burton G","year":"2010","unstructured":"Burton G J, Jauniaux E: Oxidative stress. Best Pract Res Clin Obstet Gynaecol. 2010"},{"key":"861_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/09540260600581993","volume":"18","author":"SP Mahadik","year":"2006","unstructured":"Mahadik SP, Pillai A, Joshi S, Foster A: Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia. Int Rev Psychiatry. 2006, 18: 119-131. 10.1080\/09540260600581993.","journal-title":"Int Rev Psychiatry"},{"key":"861_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/cbf.940","volume":"20","author":"M Kuloglu","year":"2002","unstructured":"Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N: Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002, 20: 171-175. 10.1002\/cbf.940.","journal-title":"Cell Biochem Funct"},{"key":"861_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0920-9964(02)00352-3","volume":"62","author":"XY Zhang","year":"2003","unstructured":"Zhang XY, Zhou DF, Cao LY, Chen DC, Zhu FY, Wu GY: Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr Res. 2003, 62: 245-250. 10.1016\/S0920-9964(02)00352-3.","journal-title":"Schizophr Res"},{"key":"861_CR9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0278-5846(02)00220-8","volume":"26","author":"O Akyol","year":"2002","unstructured":"Akyol O, Herken H, Uz E, Fadillioglu E, Unal S, Sogut S, Ozyurt H, Sava\u015f HA: The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant\/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry. 2002, 26: 995-1005. 10.1016\/S0278-5846(02)00220-8.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"861_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","volume":"81","author":"XY Zhang","year":"2006","unstructured":"Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, Zhou DF: Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res. 2006, 81: 291-300. 10.1016\/j.schres.2005.10.011.","journal-title":"Schizophr Res"},{"key":"861_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pnpbp.2007.08.003","volume":"32","author":"L Ben Othmen","year":"2008","unstructured":"Ben Othmen L, Mechri A, Fendri C, Bost M, Chazot G, Gaha L, Kerkeni A: Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings. Prog Neuro-psychopharmacol Biol Psychiatry. 2008, 32: 155-159. 10.1016\/j.pnpbp.2007.08.003.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"861_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.mp.4000789","volume":"6","author":"H Herken","year":"2001","unstructured":"Herken H, Uz E, Ozyurt H, Sogut S, Virit O, Akyol O: Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry. 2001, 6: 66-73. 10.1038\/sj.mp.4000789.","journal-title":"Mol Psychiatry"},{"key":"861_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0022-3956(98)00028-4","volume":"32","author":"JK Yao","year":"1998","unstructured":"Yao JK, Reddy R, Mc Elhinny LG, Van Kammen DP: Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. J Psychiatr Res. 1998, 32: 385-391. 10.1016\/S0022-3956(98)00028-4.","journal-title":"J Psychiatr Res"},{"key":"861_CR14","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/S0006-3223(98)00184-X","volume":"45","author":"JK Yao","year":"1999","unstructured":"Yao JK, Reddy RD, Van Kammen DP: Human plasma glutathione peroxidase and symptom severity in schizophrenia. Biol Psychiatry. 1999, 45: 1512-1515. 10.1016\/S0006-3223(98)00184-X.","journal-title":"Biol Psychiatry"},{"key":"861_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0006-3223(91)90298-Z","volume":"30","author":"R Reddy","year":"1991","unstructured":"Reddy R, Sahebarao MP, Mukherjee S, Murthy JN: Enzymes of the antioxidant defense system in chronic schizophrenic patients. Biol Psychiatry. 1991, 30: 409-412. 10.1016\/0006-3223(91)90298-Z.","journal-title":"Biol Psychiatry"},{"key":"861_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s002130100860","volume":"158","author":"N Srivastava","year":"2001","unstructured":"Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Srimal RC, Seth PK, Dikshit M: Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients. Psychopharmacology (Berl). 2001, 158: 140-145. 10.1007\/s002130100860.","journal-title":"Psychopharmacology (Berl)"},{"key":"861_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000077368","volume":"49","author":"G Dakhale","year":"2004","unstructured":"Dakhale G, Khanzode S, Khanzode S, Saoji A, Khobragade L, Turankar A: Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology. 2004, 49: 205-209. 10.1159\/000077368.","journal-title":"Neuropsychobiology"},{"key":"861_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","volume":"121","author":"PK Ranjekar","year":"2003","unstructured":"Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP: Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res. 2003, 121: 109-122. 10.1016\/S0165-1781(03)00220-8.","journal-title":"Psychiatry Res"},{"key":"861_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ridd.2007.08.001","volume":"29","author":"E Carmeli","year":"2008","unstructured":"Carmeli E, Bachar A, Barchad S, Morad M, Merrick J: Antioxidant status in the serum of persons with intellectual disability and hypothyroidism: a pilot study. Res Dev Disabil. 2008, 29: 431-438. 10.1016\/j.ridd.2007.08.001.","journal-title":"Res Dev Disabil"},{"key":"861_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.plefa.2003.08.010","volume":"69","author":"DR Evans","year":"2003","unstructured":"Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP: Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins Leukot Essent Fatty Acids. 2003, 69: 393-399. 10.1016\/j.plefa.2003.08.010.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"861_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1468-1331.2005.01000.x","volume":"12","author":"R Pulido","year":"2005","unstructured":"Pulido R, Jimenez-Escrig A, Orensanz L, Saura-Calixto F, Jimenez-Escrig A: Study of plasma antioxidant status in Alzheimer's disease. Eur J Neurol. 2005, 12: 531-535. 10.1111\/j.1468-1331.2005.01000.x.","journal-title":"Eur J Neurol"},{"key":"861_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1440-1819.2006.01532.x","volume":"60","author":"B Ustundag","year":"2006","unstructured":"Ustundag B, Atmaca M, Kirtas O, Selek S, Metin K, Tezcan E: Total antioxidant response in patients with schizophrenia. Psychiatry Clin Neurosci. 2006, 60: 458-464. 10.1111\/j.1440-1819.2006.01532.x.","journal-title":"Psychiatry Clin Neurosci"},{"key":"861_CR23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nbd.2008.11.018","volume":"3","author":"SJ Wood","year":"2009","unstructured":"Wood SJ, Berjer GE, Wellard RM, Proffitt TM, Mc Conchie M, Berk M, et al: Medial tempral lobe glutathione concentration in first episode psychosis: A1H-MRS investigation. Neurobiol Dis. 2009, 3: 354-357.","journal-title":"Neurobiol Dis"},{"key":"861_CR24","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","volume":"12","author":"KQ Do","year":"2000","unstructured":"Do KQ, Trabesinger AH, Kirsten-Kruger M, Lauer CJ, Dydak U, Hell D, Holsboer F, Boesiger P, Cu\u00e9nod M: Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci. 2000, 12: 3721-3728. 10.1046\/j.1460-9568.2000.00229.x.","journal-title":"Eur J Neurosci"},{"key":"861_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1155\/2006\/248387","volume":"22","author":"JK Yao","year":"2006","unstructured":"Yao JK, Leonard S, Reddy R: Altered glutathione redox state in schizophrenia. Dis Markers. 2006, 22: 83-93.","journal-title":"Dis Markers"},{"key":"861_CR26","first-page":"157","volume":"9","author":"D Pavlovic","year":"2002","unstructured":"Pavlovic D, Tamburic V, Stojanovic I, Kocic G, Jevtovic T, Dordevic V: Oxidative stress asmarkers of positive symptoms in schizophrenia. Med Biol. 2002, 9: 157-161.","journal-title":"Med Biol"},{"key":"861_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1515\/CCLM.2000.201","volume":"38","author":"I Altuntas","year":"2000","unstructured":"Altuntas I, Aksoy H, Coskun I, Cayk\u00f6yl\u00fc A, Ak\u00e7ay F: Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin Chem Lab Med. 2000, 38: 1277-1281. 10.1515\/CCLM.2000.201.","journal-title":"Clin Chem Lab Med"},{"key":"861_CR28","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.pnpbp.2009.06.018","volume":"33","author":"M Raffa","year":"2009","unstructured":"Raffa M, Mechri A, Othman LB, Fendri C, Gaha L, Kerkeni A: Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry. 2009, 33: 1178-1183. 10.1016\/j.pnpbp.2009.06.018.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"861_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.psychres.2006.03.024","volume":"153","author":"M Saadat","year":"2007","unstructured":"Saadat M, Mobayen F, Farrashbandi H: Genetic polymorphisms of glutathione S-transferase T1: a candidate genetic modifier of individual susceptibilty to schizophrenia. Psychiatry Res. 2007, 153: 87-91. 10.1016\/j.psychres.2006.03.024.","journal-title":"Psychiatry Res"},{"key":"861_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1086\/507566","volume":"79","author":"M Tosic","year":"2006","unstructured":"Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F, et al: Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet. 2006, 79: 586-592. 10.1086\/507566.","journal-title":"Am J Hum Genet"},{"key":"861_CR31","volume-title":"DSM-IV-TR. Diagnostic and Statistical Manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association: DSM-IV-TR. Diagnostic and Statistical Manual of mental disorders. 2000, Washington DC: American Psychiatric Press, fourth","edition":"fourth"},{"key":"861_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"S Marklund","year":"1974","unstructured":"Marklund S, Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974, 47: 469-474. 10.1111\/j.1432-1033.1974.tb03714.x.","journal-title":"Eur J Biochem"},{"key":"861_CR33","first-page":"444","volume":"12","author":"WA Gunzler","year":"1974","unstructured":"Gunzler WA, Kremers H, Flohe L: An improved coupled test procedure for glutathione peroxidase in blood. Z Klin Biochem. 1974, 12: 444-448.","journal-title":"Z Klin Biochem"},{"key":"861_CR34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9258(19)50881-X","volume":"195","author":"B Beer","year":"1952","unstructured":"Beer B, Sizer W: A spectrophotometry method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952, 195: 133-139.","journal-title":"J Biol Chem"},{"key":"861_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0076-6879(81)77050-2","volume-title":"Methods enzymol detoxification and drug metabolism: conjugation and related systems","author":"TP Akerboom","year":"1981","unstructured":"Akerboom TP, Sies DH: Assay of glutathione, glutathione disulfide and glutathione mixed disulfides in biological samples. Methods enzymol detoxification and drug metabolism: conjugation and related systems. Edited by: Jakoly W. 1981, London: Academic Press, 373-382."},{"key":"861_CR36","volume-title":"Scale for the Assessment of Negative Symptoms","author":"NC Andreasen","year":"1983","unstructured":"Andreasen NC: Scale for the Assessment of Negative Symptoms. 1983, University of Iowa, Iowa City IA"},{"key":"861_CR37","unstructured":"SPSS.10.0 statistical package for the Social sciences (SPSS) for windows, version 10.0. 1994, Chicago.IL: SPSS Inc"},{"key":"861_CR38","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","volume":"7","author":"S Prabakaran","year":"2004","unstructured":"Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, et al: Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. 2004, 7: 684-697.","journal-title":"Mol Psychiatry"},{"key":"861_CR39","doi-asserted-by":"publisher","first-page":"e1944","DOI":"10.1371\/journal.pone.0001944","volume":"4","author":"D Matsuzawa","year":"2008","unstructured":"Matsuzawa D, Obata T, Shirayama Y, Nonaka H, Kanazawa Y, Yoshitome E, Takanashi J, Matsuda T, Shimizu E, Ikehira H, Iyo M, Hashimoto K: Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study. PLoS ONE. 2008, 4: e1944-","journal-title":"PLoS ONE"},{"key":"861_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s10334-005-0012-0","volume":"18","author":"M Terpstra","year":"2005","unstructured":"Terpstra M, Vaughan TJ, Ugurbil K, Lim KO, Schulz SC, Gruetter R: Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia. MAGMA. 2005, 18: 276-282. 10.1007\/s10334-005-0012-0.","journal-title":"MAGMA"},{"key":"861_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-244X-11-26","volume":"11","author":"JA Mico","year":"2011","unstructured":"Mico JA, Rojas-Corrales MO, Gibert-Rahola J, Parellada M, Moreno D, Fraguas D, et al: Reduced antioxidant defense in early onset first-episode psychosis: a case control study. BMC Psychiatry. 2011, 11: 26-10.1186\/1471-244X-11-26.","journal-title":"BMC Psychiatry"},{"key":"861_CR42","first-page":"66","volume":"15","author":"SP Mahadik","year":"1995","unstructured":"Mahadik SP, Mukherjee S, Correnti EE, Scheffer R: Elevated levels of lipid peroxidation production plasma of drug-naive patients at the onset of psychosis. Schizophr Res. 1995, 15: 66-","journal-title":"Schizophr Res"},{"key":"861_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0920-9964(95)00049-6","volume":"19","author":"SP Mahadik","year":"1996","unstructured":"Mahadik SP, Mukherjee S: Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res. 1996, 19: 1-17. 10.1016\/0920-9964(95)00049-6.","journal-title":"Schizophr Res"},{"key":"861_CR44","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.pnpbp.2006.03.034","volume":"6","author":"S Ersan","year":"2006","unstructured":"Ersan S, Bakir S, Erdal Ersan E, Dogan O: Examination of free radical metabolism and antioxidant defense system elements in patients with obsessive-compulsive disorder. Prog neuropsychopharmacol Biol Psychiatry. 2006, 6: 1039-1042.","journal-title":"Prog neuropsychopharmacol Biol Psychiatry"},{"key":"861_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00004850-200403000-00006","volume":"19","author":"ME Ozcan","year":"2004","unstructured":"Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O: Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol. 2004, 19: 89-95. 10.1097\/00004850-200403000-00006.","journal-title":"Int Clin Psychopharmacol"},{"key":"861_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neulet.2007.05.016","volume":"421","author":"R Machado-Vieira","year":"2007","unstructured":"Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, Cereser V, Da Silva V, et al: Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett. 2007, 421: 33-36. 10.1016\/j.neulet.2007.05.016.","journal-title":"Neurosci Lett"},{"key":"861_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1042\/bj3240025","volume":"324","author":"S Baez","year":"1997","unstructured":"Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B: Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J. 1997, 324: 25-28.","journal-title":"Biochem J"},{"key":"861_CR48","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C","volume":"55","author":"AH Stokes","year":"1999","unstructured":"Stokes AH, Hastings TG, Vrana KE: Cytotoxic and genotoxic potential of dopamine. J Neurosci Res. 1999, 55: 659-665. 10.1002\/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C.","journal-title":"J Neurosci Res"},{"key":"861_CR49","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","volume":"148","author":"KL Davis","year":"1991","unstructured":"Davis KL, Kahn RS, Ko G, Davidson M: Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 1991, 148: 1474-1486.","journal-title":"Am J Psychiatry"},{"key":"861_CR50","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1017\/S1461145707008401","volume":"11","author":"F Ng","year":"2008","unstructured":"Ng F, Berk M, Dean O, Bush AI: Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008, 11: 851-876.","journal-title":"Int J Neuropsychopharmacol"},{"key":"861_CR51","doi-asserted-by":"publisher","first-page":"16621","DOI":"10.1073\/pnas.0706778104","volume":"104","author":"R Gysin","year":"2007","unstructured":"Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, et al: Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci USA. 2007, 104: 16621-16626. 10.1073\/pnas.0706778104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"861_CR52","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000103641","volume":"58","author":"S Younes-Mhenni","year":"2007","unstructured":"Younes-Mhenni S, Frih-Ayed M, Kerkeni A, Bost M, Chazot G: Peripheral blood markers of oxidative stress in Parkinson's disease. Eur Neurol. 2007, 58: 78-83.","journal-title":"Eur Neurol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-11-124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-11-124\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-11-124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T07:26:12Z","timestamp":1638170772000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-11-124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-11-124","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,2]]},"article-number":"124"}}